María del Carmen
Chillón Santos
Forscherin seit 2011
Hospital del Bierzo
Ponferrada, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital del Bierzo (2)
2021
-
Prognostic significance of FLT3-ITD length in AML patients treated with intensive regimens
Scientific Reports, Vol. 11, Núm. 1
2013
-
MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenström's macroglobulinemia
Leukemia, Vol. 27, Núm. 8, pp. 1722-1728